Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 3 out of 25 pages
Exam (elaborations)

NAMS Menopause Certification Exam 2026/2027 Comprehensive Study Guide, Practice Questions, Test Bank Review, and Exam Preparation Manual

Document preview thumbnail
Preview 3 out of 25 pages

Comprehensive NAMS Menopause Certification Exam Study Guide 2026/2027 designed to help healthcare professionals prepare for certification examinations and competency assessments in menopause care and women's health. Covers essential topics including menopausal physiology, hormonal and nonhormonal treatment options, symptom management, healthy aging, cardiovascular health, bone health, genitourinary syndrome of menopause, patient counseling, risk assessment, evidence-based clinical practice, and individualized care planning. Includes practice questions, test bank review materials, detailed study notes, review exercises, and exam-focused summaries to strengthen clinical knowledge and improve certification readiness. Ideal for healthcare professionals seeking structured preparation and comprehensive coverage of menopause management and women's midlife health concepts.

Content preview

2026/2027



NAMS Menopause Certification
Exam 2026/2027 Comprehensive
Study Guide, Practice Questions,
Test Bank Review, and Exam
Preparation Manual

Question 1:

What is the median age of natural menopause?

A. 45 years
B. 48 years
C. 51 years
D. 55 years

Correct Answer: C. 51 years

Rationale: The average (median) age of natural menopause is approximately 51 years.
This reflects the typical age when ovarian function permanently ceases. Earlier ages
(A and B) indicate premature or early menopause, while 55 years is above the normal
physiological range.


Question 2:

What is the primary hormonal change during menopause transition?

A. Increased progesterone
B. Declining estrogen levels
C. Increased insulin
D. Increased cortisol

Correct Answer: B. Declining estrogen levels

Rationale: Menopause is mainly caused by ovarian follicular depletion, leading to
reduced estrogen production. This hormonal decline is responsible for vasomotor
symptoms, bone loss, and metabolic changes.


Question 3:

,2026/2027

A 49-year-old woman with irregular periods and hot flashes is most likely in which
stage?

A. Menopause
B. Perimenopause
C. Postmenopause
D. Puberty

Correct Answer: B. Perimenopause

Rationale: Perimenopause is the transitional stage before menopause characterized by
hormonal fluctuations, irregular cycles, and vasomotor symptoms such as hot flashes.


Question 4:

Postmenopause is defined as:

A. Irregular cycles for 6 months
B. 12 consecutive months without menstruation
C. Presence of ovulation
D. Heavy menstrual bleeding

Correct Answer: B. 12 consecutive months without menstruation

Rationale: Postmenopause is clinically diagnosed after 12 months of amenorrhea,
confirming permanent cessation of ovarian function.


Question 5:

Which laboratory finding supports menopause?

A. Low FSH
B. Elevated FSH (>25 IU/L)
C. High progesterone
D. High prolactin

Correct Answer: B. Elevated FSH (>25 IU/L)

Rationale: Elevated FSH reflects decreased ovarian feedback due to low estrogen
levels and is a key diagnostic marker of menopause.


Question 6:

Most effective treatment for moderate-to-severe hot flashes:

A. Calcium
B. Hormone therapy

, 2026/2027

C. Iron supplements
D. Antibiotics

Correct Answer: B. Hormone therapy

Rationale: Estrogen therapy is the most effective treatment for vasomotor symptoms
by correcting estrogen deficiency.


Question 7:

A woman with a uterus receiving hormone therapy should be given:

A. Estrogen only
B. Estrogen + progestogen
C. Testosterone only
D. No treatment

Correct Answer: B. Estrogen + progestogen

Rationale: Progestogen protects the endometrium from estrogen-induced hyperplasia
and reduces cancer risk.


Question 8:

Recommended treatment for hot flashes in a breast cancer survivor:

A. Estrogen therapy
B. Paroxetine
C. Oral contraceptives
D. Progesterone only

Correct Answer: B. Paroxetine

Rationale: SSRIs such as paroxetine are non-hormonal and safe in estrogen-sensitive
conditions like breast cancer.


Question 9:

Contraindication for systemic hormone therapy:

A. Headache
B. Unexplained vaginal bleeding
C. Mild fatigue
D. Dry skin

Correct Answer: B. Unexplained vaginal bleeding

Document information

Uploaded on
June 2, 2026
Number of pages
25
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$27.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
0
Followers
0
Items
389
Last sold
-


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions